Carol J. Landers

14.5k total citations · 5 hit papers
108 papers, 8.1k citations indexed

About

Carol J. Landers is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Carol J. Landers has authored 108 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Genetics, 49 papers in Immunology and 43 papers in Epidemiology. Recurrent topics in Carol J. Landers's work include Inflammatory Bowel Disease (69 papers), Microscopic Colitis (35 papers) and Immunodeficiency and Autoimmune Disorders (22 papers). Carol J. Landers is often cited by papers focused on Inflammatory Bowel Disease (69 papers), Microscopic Colitis (35 papers) and Immunodeficiency and Autoimmune Disorders (22 papers). Carol J. Landers collaborates with scholars based in United States, Canada and United Kingdom. Carol J. Landers's co-authors include Stephan R. Targan, Konstantinos A. Papadakis, Charles O. Elson, Robert M. Hershberg, Michael J. Lodes, Yingzi Cong, Huiying Yang, Fergus Shanahan, Jerome I. Rotter and Madeline Fort and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Carol J. Landers

106 papers receiving 7.9k citations

Hit Papers

Bacterial flagellin is a dominant antigen in Crohn di... 1990 2026 2002 2014 2004 2004 1990 2019 2016 100 200 300 400 500

Peers

Carol J. Landers
Richard H. Duerr United States
Derek P. Jewell United Kingdom
Jean–Paul Achkar United States
Frank Seibold Switzerland
Phillip Fleshner United States
Miles Parkes United Kingdom
Felicia F. Chen United States
Richard H. Duerr United States
Carol J. Landers
Citations per year, relative to Carol J. Landers Carol J. Landers (= 1×) peers Richard H. Duerr

Countries citing papers authored by Carol J. Landers

Since Specialization
Citations

This map shows the geographic impact of Carol J. Landers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol J. Landers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol J. Landers more than expected).

Fields of papers citing papers by Carol J. Landers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol J. Landers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol J. Landers. The network helps show where Carol J. Landers may publish in the future.

Co-authorship network of co-authors of Carol J. Landers

This figure shows the co-authorship network connecting the top 25 collaborators of Carol J. Landers. A scholar is included among the top collaborators of Carol J. Landers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol J. Landers. Carol J. Landers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCarthy, Ellen T., et al.. (2025). Dietary intakes and quality of Irish adults with cystic fibrosis: Comparisons to nutrition guidelines and HEI-2020. Journal of Cystic Fibrosis. 24(6). 1073–1080. 1 indexed citations
2.
Limon, Jose J., Jie Tang, Dalin Li, et al.. (2019). Malassezia Is Associated with Crohn’s Disease and Exacerbates Colitis in Mouse Models. Cell Host & Microbe. 25(3). 377–388.e6. 311 indexed citations breakdown →
3.
Zaghiyan, Karen, Gil Melmed, Eric Vasiliauskas, et al.. (2016). Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients withDenovoCrohn’s Disease After Ileal Pouch Anal Anastomosis. Journal of Crohn s and Colitis. 11(1). 77–83. 20 indexed citations
4.
Li, Dalin, Mark S. Silverberg, Talin Haritunians, et al.. (2016). TNFRSF1B Is Associated with ANCA in IBD. Inflammatory Bowel Diseases. 22(6). 1346–1352. 7 indexed citations
5.
Targan, Stephan R., Brian G. Feagan, Séverine Vermeire, et al.. (2016). A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease. The American Journal of Gastroenterology. 111(11). 1599–1607. 289 indexed citations breakdown →
6.
Mei, Ling, et al.. (2009). Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study. Arthritis Research & Therapy. 11(6). R177–R177. 32 indexed citations
7.
Michelsen, Kathrin S., Lisa Thomas, Kent D. Taylor, et al.. (2009). IBD-Associated TL1A Gene (TNFSF15) Haplotypes Determine Increased Expression of TL1A Protein. PLoS ONE. 4(3). e4719–e4719. 74 indexed citations
8.
Takedatsu, Hidetoshi, Kathrin S. Michelsen, Bo Wei, et al.. (2008). TL1A (TNFSF15) Regulates the Development of Chronic Colitis by Modulating Both T-Helper 1 and T-Helper 17 Activation. Gastroenterology. 135(2). 552–567.e2. 209 indexed citations
9.
Papadakis, Konstantinos A., Huiying Yang, Andrew Ippoliti, et al.. (2007). Anti-flagellin (CBir1) phenotypic and genetic Crohnʼs disease associations. Inflammatory Bowel Diseases. 13(5). 524–530. 83 indexed citations
10.
Papadakis, Konstantinos A., Daocheng Zhu, John Prehn, et al.. (2005). Dominant Role for TL1A/DR3 Pathway in IL-12 plus IL-18-Induced IFN-γ Production by Peripheral Blood and Mucosal CCR9+ T Lymphocytes. The Journal of Immunology. 174(8). 4985–4990. 103 indexed citations
11.
Targan, Stephan R., Carol J. Landers, Huiying Yang, et al.. (2005). Antibodies to CBir1 Flagellin Define a Unique Response That Is Associated Independently With Complicated Crohn’s Disease. Gastroenterology. 128(7). 2020–2028. 356 indexed citations
12.
Papadakis, Konstantinos A., John Prehn, Carol J. Landers, et al.. (2004). TL1A Synergizes with IL-12 and IL-18 to Enhance IFN-γ Production in Human T Cells and NK Cells. The Journal of Immunology. 172(11). 7002–7007. 114 indexed citations
13.
Papadakis, Konstantinos A., Carol J. Landers, John Prehn, et al.. (2003). CC Chemokine Receptor 9 Expression Defines a Subset of Peripheral Blood Lymphocytes with Mucosal T Cell Phenotype and Th1 or T-Regulatory 1 Cytokine Profile. The Journal of Immunology. 171(1). 159–165. 80 indexed citations
14.
Landers, Carol J., Offer Cohavy, Rajeev Misra, et al.. (2002). Selected loss of tolerance evidenced by Crohn's disease–associated immune responses to auto- and microbial antigens. Gastroenterology. 123(3). 689–699. 348 indexed citations
15.
Taylor, Kent D., Huiying Yang, Carol J. Landers, et al.. (2001). ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease. Gastroenterology. 120(6). 1347–1355. 176 indexed citations
16.
Sutton, Christopher L., Jeong Hun Kim, Bo Wei, et al.. (2000). Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology. 119(1). 23–31. 172 indexed citations
17.
Kaditis, Athanasios G., Jean Perrault, William J. Sandborn, et al.. (1998). Antineutrophil Cytoplasmic Antibody Subtypes in Children and Adolescents After Ileal Pouch‐Anal Anastomosis for Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. 26(4). 386–392. 1 indexed citations
18.
Targan, Stephan R., Carol J. Landers, Alda Vidrich, & Albert J. Czaja. (1995). High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 108(4). 1159–1166. 142 indexed citations
19.
Duerr, Richard H., Stephan R. Targan, Carol J. Landers, Lloyd R. Sutherland, & Fergus Shanahan. (1991). Anti-Neutrophil Cytoplasmic Antibodies in Ulcerative Colitis. Gastroenterology. 100(6). 1590–1596. 46 indexed citations
20.
Shanahan, Fergus, Carol J. Landers, Richard H. Duerr, & Stephan R. Targan. (1991). Neutrophil autoantibodies as disease markers for ulcerative colitis. Immunologic Research. 10(3-4). 479–484. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026